Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2021

Jul 13, 2021

60507_rns_2021-07-13_b67ebc0d-db37-4407-97eb-228dabec94f2.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

July 13, 2021

The Corporate Relationship Dept. The Manager, Listing Dept.
BSE Limited The National Stock Exchange of India Ltd.
1st Floor, P.J.Towers Exchange Plaza, 5th Floor,
Dalal Street, Fort Plot No. C/1, G Block
Mumbai –
400 001
Bandra-Kurla Complex, Bandra (E)
Scrip Code: 500680 Mumbai –
400 051
Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation regarding loss of share certificates and issue of duplicate share certificates

Pursuant to Regulation 39 (3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificate(s) from the below Shareholder:

Sr. Name Folio No. Certificate Number Dist Nos. Dist Nos.
No. No. of Shares From To
1. Mr. Buvaneswaram K. P 0006577 146898 10 10675261 10675270
Mr. Ramadurai Chellammal

We shall issue the duplicate Share Certificate(s) upon completion of necessary formalities by the shareholder.

Please take the above on record.

Thanking you,

Yours truly,

For Pfizer Limited

Prajeet Nair Company Secretary

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerindia.com